Sokoll L - Search Results

1

Updating risk prediction tools: a case study in prostate cancer.

Ankerst DP, Koniarski T, Liang Y, Leach RJ, Feng Z, Sanda MG, Partin AW, Chan DW, Kagan J, Sokoll L, Wei JT, Thompson IM. Ankerst DP, et al. Among authors: sokoll l. Biom J. 2012 Jan;54(1):127-42. doi: 10.1002/bimj.201100062. Epub 2011 Nov 17. Biom J. 2012. PMID: 22095849 Free PMC article.

2

Prostate-specific antigen. Its discovery and biochemical characteristics.

Sokoll LJ, Chan DW. Sokoll LJ, et al. Urol Clin North Am. 1997 May;24(2):253-9. doi: 10.1016/s0094-0143(05)70370-0. Urol Clin North Am. 1997. PMID: 9126221 Free article. Review.

3

Critical analysis of false elevations in PSA results reported with the Abbott AxSYM assay.

Sokoll LJ, Partin AW, Nelson JB, Chan DW. Sokoll LJ, et al. Prostate. 1999 Jan 1;38(1):79-80. doi: 10.1002/(sici)1097-0045(19990101)38:1<79::aid-pros10>3.0.co;2-c. Prostate. 1999. PMID: 9973113 No abstract available.

4

Prostate-specific antigen: update 1997.

Chan DW, Sokoll LJ. Chan DW, et al. Among authors: sokoll lj. J Int Fed Clin Chem. 1997 Sep;9(3):120-5. J Int Fed Clin Chem. 1997. PMID: 10174623 Review.

5

Prostate-specific antigen: advances and challenges.

Chan DW, Sokoll LJ. Chan DW, et al. Among authors: sokoll lj. Clin Chem. 1999 Jun;45(6 Pt 1):755-6. Clin Chem. 1999. PMID: 10351982 No abstract available.

6

Clinical analyzers. Immunoassays.

Sokoll LJ, Chan DW. Sokoll LJ, et al. Anal Chem. 1999 Jun 15;71(12):356R-362R. doi: 10.1021/a1999910i. Anal Chem. 1999. PMID: 10384792 Review. No abstract available.

7

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.

Brawer MK, Cheli CD, Neaman IE, Goldblatt J, Smith C, Schwartz MK, Bruzek DJ, Morris DL, Sokoll LJ, Chan DW, Yeung KK, Partin AW, Allard WJ. Brawer MK, et al. Among authors: sokoll lj. J Urol. 2000 May;163(5):1476-80. J Urol. 2000. PMID: 10751861

8

Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays.

Vessella RL, Lange PH, Partin AW, Chan DW, Sokoll LJ, Sasse EA, Crawford ED. Vessella RL, et al. Among authors: sokoll lj. Urology. 2000 Jun;55(6):909-14. doi: 10.1016/s0090-4295(00)00461-1. Urology. 2000. PMID: 10840107 Clinical Trial.

9

WHO first international standards for prostate-specific antigen: the beginning of the end for assay discrepancies?

Chan DW, Sokoll LJ. Chan DW, et al. Among authors: sokoll lj. Clin Chem. 2000 Sep;46(9):1291-2. Clin Chem. 2000. PMID: 10973856 No abstract available.

10

Redesigned proficiency testing materials improve survey outcomes for prostate-specific antigen. A College of American Pathologists Ligand Assay Survey tool.

Sokoll LJ, Witte DL, Klee GG, Chan DW. Sokoll LJ, et al. Arch Pathol Lab Med. 2000 Nov;124(11):1608-13. doi: 10.5858/2000-124-1608-RPTMIS. Arch Pathol Lab Med. 2000. PMID: 11079010 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page